Update on Strategies to Reduce Early Brain Injury after Subarachnoid Hemorrhage.

Area of Science:

• Neuroscience
• Translational Medicine
• Critical Care

Background:

• Early brain injury (EBI) following aneurysmal subarachnoid hemorrhage (SAH) is a critical determinant of patient outcomes.
• Despite advances in understanding EBI pathophysiology, effective therapeutic interventions remain elusive.
• This review focuses on recent advancements in EBI research over the past five years.

Purpose of the Study:

• To summarize recent progress in EBI research.
• To identify and discuss potential therapeutic targets for EBI.
• To bridge the gap between basic science discoveries and clinical application.

Main Methods:

• Review of recent (last 5 years) translational and clinical studies on EBI.
• Analysis of converging pathophysiologic pathways.
• Identification of emerging mechanistic components and biomarkers.

Main Results:

• Key pathways identified include antioxidant delivery (Sirt1/Nrf2) for reactive oxygen species, NLRP3 inflammasome/microglial polarization for inflammation, and PI3K/Akt for apoptosis.
• Emerging areas of focus include microcirculatory failure and ferroptosis.
• Development of radiographic and biofluid markers aims to facilitate clinical translation.
• Significant exponential growth in EBI research observed.

Conclusions:

• Translational studies are converging on specific molecular pathways relevant to EBI.
• Further clinical studies targeting these specific pathophysiologic mechanisms are crucial.
• Identifying novel therapeutic approaches for EBI is an active and evolving area of research.